- Home
- RLAY vs IPAR Comparison
RLAY vs IPAR Comparison
Compare RLAY & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | IPAR |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RLAY | IPAR |
|---|---|---|
| Price | $12.79 | $91.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $19.50 | ★ $116.60 |
| AVG Volume (30 Days) | ★ 3.6M | 230.0K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ 31.78 | 2.34 |
| EPS | N/A | ★ 5.24 |
| Revenue | $15,355,000.00 | ★ $1,317,700,000.00 |
| Revenue This Year | N/A | $3.86 |
| Revenue Next Year | $324.03 | $7.89 |
| P/E Ratio | ★ N/A | $17.35 |
| Revenue Growth | ★ 53.44 | 21.26 |
| 52 Week Low | $2.71 | $77.21 |
| 52 Week High | $17.32 | $142.50 |
Technical Indicators
Market Signals| Indicator | RLAY | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 45.72 |
| Support Level | $6.67 | $87.60 |
| Resistance Level | $17.32 | $99.02 |
| Average True Range (ATR) | 1.05 | 2.74 |
| MACD | -0.54 | -0.30 |
| Stochastic Oscillator | 9.98 | 28.89 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.